森麒麟(002984.SZ):今年已正式為芬蘭諾記輪胎旗下主品牌“Nokian”全球最高端的雪地胎產品供貨
格隆匯11月9日丨有投資者網上向森麒麟(002984.SZ)提問,“諾記輪胎和森麒麟去年全球官宣合作,目前合作進展如何了?雪地胎出貨情況如何,後續有沒有收購諾記輪胎佈局歐洲市場計劃?”
公司回覆表示,公司今年已正式為芬蘭諾記輪胎旗下主品牌“Nokian”全球最高端的雪地胎產品供貨,後續合作將持續進行。擁有百年曆史積澱的諾記輪胎是全球輪胎行業公認的“冰雪胎王者”,在冬季輪胎市場具備絕對領導地位。目前雙方合作態勢很好,希望未來各方面合作不斷加深。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.